Intelligent Bio Solutions (INBS) Cash from Financing Activities (2020 - 2024)
Intelligent Bio Solutions has reported Cash from Financing Activities over the past 4 years, most recently at $10.8 million for Q1 2024.
- Quarterly results put Cash from Financing Activities at $10.8 million for Q1 2024, up 526.97% from a year ago — trailing twelve months through Mar 2024 was $12.5 million (down 42.58% YoY), and the annual figure for FY2023 was $1.4 million, changed.
- Cash from Financing Activities for Q1 2024 was $10.8 million at Intelligent Bio Solutions, up from $46110.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for INBS hit a ceiling of $19.6 million in Q4 2020 and a floor of $46110.0 in Q2 2023.
- Median Cash from Financing Activities over the past 4 years was $1.7 million (2023), compared with a mean of $5.2 million.
- Peak annual rise in Cash from Financing Activities hit 526.97% in 2024, while the deepest fall reached 526.97% in 2024.
- Intelligent Bio Solutions' Cash from Financing Activities stood at $19.6 million in 2020, then crashed by 97.46% to $498100.0 in 2021, then crashed by 90.74% to $46110.0 in 2023, then soared by 23255.19% to $10.8 million in 2024.
- The last three reported values for Cash from Financing Activities were $10.8 million (Q1 2024), $46110.0 (Q2 2023), and $1.7 million (Q1 2023) per Business Quant data.